The latest biotech news

university ghent grassoline grass biofuel

News and Trends 13 Apr 2017

Belgian Research takes first steps to make Biofuel out of Grass

Researchers from the University of Ghent are using bacteria to turn grass into chemicals for bioplastics and biofuel. Could this process be scaled up to fuel planes? A grass bioconversion project is being developed at the Centre for Microbial Ecology and Technology (CMET) of the University of Ghent, and it has recently taken an important step forward. […]

April 13, 2017 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2017

Coming from Behind: How Italy is Revamping its Biotech Industry

Italy’s biotech industry lags behind in Europe, but the situation is starting to change with coordinated efforts in research, finance and organization. While ‘European biotech’ brings to mind France, Germany and the UK, Italy is cultivating its own thriving ecosystem. It claims internationally renowned scientific research institutions, including the University of Perugia and the San Raffaele […]

April 13, 2017 - 5 minutesmins - By External Contributor

News and Trends 12 Apr 2017

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of its most advanced candidate tackling antibiotic resistances. Polyphor is a clinical stage pharma developing a specific class of so called ‘macrocyclic drugs‘, which are chemically defined by a ring structure. The company’s pipeline is covering a broad range of diseases such as […]

April 12, 2017 - 3 minutesmins - By Melanie De Almeida

SIRION Biotech cell therapy lentivirus lentiboost

News and Trends 12 Apr 2017

Taking Cell Therapy one Step Further with this Boost Reagent

Cell therapy is revolutionizing medicine, here’s how the latest technology can help overcome the major challenges stopping it from taking over the market. Offering unprecedented possibilities to treat some of the most challenging diseases, cell therapy is stealing the show in the biotech space. Strimvelis, the first hematopoietic stem cell (HSC) gene therapy is already […]

April 12, 2017 - 4 minutesmins - By External Contributor

News and Trends 11 Apr 2017

French Microbiome Startup Gets a Series A Funding Boost to Regulate Appetite

The French biotech startup TargEDys has extended its series A funding initiated in April 2016 by €3.5M to accelerate the development of its pipeline. After raising an initial €5.8M in a series A funding round from big names like Seventure Partners, TargEDys has now raked an additional €3.5M from the Zaluvida group. The company has also appointed Christoph […]

April 11, 2017 - 3 minutesmins - By Melanie De Almeida

Eyevensis Eye Gene Therapy Approval France

News and Trends 11 Apr 2017

France Approves Trials for the First Eye Gene Therapy Free of Viral DNA

Eyevensys has received regulatory approval in France to start clinical trials using eye gene therapy technology that eliminates the need for viral vectors. The French biotech Eyevensys has been cleared by the French Product Security Regulatory Agency (ANSM) to proceed into the clinic with its EyeCET platform. The company is developing this gene therapy platform […]

April 11, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Apr 2017

Illumina Enters Europe to Take Over the Prenatal Diagnostics Market

Illumina has launched its NGS-based non-invasive prenatal test (NIPT) in Europe and is ready to position itself as the top dog in this competitive market. The US next-generation sequencing (NGS) giant Illumina has launched its VeriSeq NIPT Solution in the EU today. It’s an NGS-based kit that allows for rapid testing of the fetal chromosome status using a single maternal […]

April 11, 2017 - 2 minutesmins - By Melanie De Almeida

Mission Therapeutics Parkinsons research grant

News and Trends 11 Apr 2017

New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK

Mission Therapeutics has received a grant to support the development of a novel approach to treating Parkinson’s that is attracting top partners worldwide. Right on time for World Parkinson’s Day today, Mission Therapeutics has announced it has been awarded a research grant from the Michael J. Fox Foundation in the US. Named after its founder, the star of […]

April 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Apr 2017

The Biggest European Medtech Exit of 2017 Just Happened

The medtech company Symetis, specialized in heart valve replacements, today announced its acquisition by Boston Scientific in a hefty €411M ($435M) deal. Symetis is a Swiss medtech company and one of the key players on the European transcatheter aortic valve implantation (TAVI) market. After launching a promising €55M IPO on Euronext Paris in March, the company has now […]

April 10, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 10 Apr 2017

Swiss-Danish Collaboration will use Synbio to Produce a B Vitamin

Two startups in the fields of synthetic biology, Biosyntia and FGen, have struck a partnership to identify promising microbial strains. The objective is to find a strain that enables bioproduction of a B vitamin. The driving force of this new partnership between Biosyntia, Denmark, and ETH Zurich, and brands itself as a CRO for biologics […]

April 10, 2017 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 6 Apr 2017

This New Biotech counts with the Largest Antibiotic Resistance Database

Curetis has launched Ares Genetics, a company that will use the biggest antibiotic resistance genetic database to advance the diagnose of infections. Ares Genetics, the new subsidiary of Curetis, will investigate the genetic foundation of antibiotic resistance to develop new approaches for the rapid diagnose of specific resistance in patients with infections, as well as tools to […]

April 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Apr 2017

Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy

Evotec and Sanofi have achieved preclinical proof-of-concept for a new beta cell therapy for diabetes, triggering a €3M milestone payment from Sanofi. In 2015, Sanofi and the German CRO Evotec partnered to jointly develop a beta cell replacement therapy for the treatment of diabetes in a deal that could reach more than €300M in potential milestone payments. […]

April 6, 2017 - 2 minutesmins - By Melanie De Almeida

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Belgian Research takes first steps to make Biofuel out of Grass

Coming from Behind: How Italy is Revamping its Biotech Industry

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Taking Cell Therapy one Step Further with this Boost Reagent

French Microbiome Startup Gets a Series A Funding Boost to Regulate Appetite

France Approves Trials for the First Eye Gene Therapy Free of Viral DNA

Illumina Enters Europe to Take Over the Prenatal Diagnostics Market

New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK

The Biggest European Medtech Exit of 2017 Just Happened

Swiss-Danish Collaboration will use Synbio to Produce a B Vitamin

This New Biotech counts with the Largest Antibiotic Resistance Database

Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy

Subscribe to our newsletter to get the latest biotech news!